Melanie B. Fukui
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Melanie B. Fukui has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Richard Adam Rovin
Aurora Neuroscience Innovation Institute
5 shared publications Amin Kassam
Affiliation Aurora Neuroscience Innovation Institute, Milwaukee, Wisconsin, United States of America
2 shared publications- Amin Kassam
The Ottawa Hospital
2 shared publications - Carolyn Cidis Meltzer
From the RSNA Board of Directors
2 shared publications Daniel Raymond
Affiliation Department of Biology, Northern Michigan University, Marquette, Michigan, United States of America
2 shared publications- Martin J. Corsten
Aurora Neuroscience Innovation Institute, Milwaukee, Wisconsin, United States
2 shared publications
Latest Publications
- 4 March 2026
- Published by Wolters Kluwer Health in Operative Neurosurgery
The “Trimeric” Anterolateral Thigh Free Flap: A Novel Technique for the Reconstruction of Complex Cranio-Orbital and Middle Skull Base Defects
BACKGROUND AND IMPORTANCE: The anterolateral thigh (ALT) free flap is a versatile reconstructive option for complex 3-dimensional defects of the head and neck. It can be tailored for cutaneous, fasciocutaneous, musculocutaneous, or flow-through configurations based on patient needs. Chimeric flaps comprise distinct tissue components on a shared vascular pedicle and allow simultaneous functional and aesthetic reconstruction in a single stage. We present a novel extension of this concept incorporating a third vascularized component to address multilayer skull base defects. CLINICAL PRESENTATION: A 65-year-old man with an atypical (World Health Organization Grade II) sphenoid wing meningioma infiltrating the left anterior and middle cranial base, infratemporal fossa, and masticator space developed necrotizing fasciitis and flap failure after initial resection. The resulting skull base defect involved the middle cranial fossa, orbit, and maxilla, with communication into the nasopharynx. Conventional staged reconstructions or local flaps were not feasible because of limited tissue diversity and recipient vessels. A “trimeric” ALT free flap was therefore designed, incorporating 3 tissue components: vastus lateralis muscle, tensor fascia lata, and rectus femoris muscle. Each of these was supplied by perforators from the descending branch of the lateral circumflex femoral artery. This configuration enabled reconstruction of the middle cranial fossa floor, vascularized dural coverage, and restoration of temporalis contour in a single operation. CONCLUSION: This first reported trimeric ALT flap achieved comprehensive restoration of complex cranio-orbital and skull base defects, providing a durable, vascularized, and anatomically adaptable solution for single-stage reconstruction.
- 4 March 2026
- Published by Wolters Kluwer Health in Operative Neurosurgery
The “Trimeric” Anterolateral Thigh Free Flap: A Novel Technique for the Reconstruction of Complex Cranio-Orbital and Middle Skull Base Defects
BACKGROUND AND IMPORTANCE: The anterolateral thigh (ALT) free flap is a versatile reconstructive option for complex 3-dimensional defects of the head and neck. It can be tailored for cutaneous, fasciocutaneous, musculocutaneous, or flow-through configurations based on patient needs. Chimeric flaps comprise distinct tissue components on a shared vascular pedicle and allow simultaneous functional and aesthetic reconstruction in a single stage. We present a novel extension of this concept incorporating a third vascularized component to address multilayer skull base defects. CLINICAL PRESENTATION: A 65-year-old man with an atypical (World Health Organization Grade II) sphenoid wing meningioma infiltrating the left anterior and middle cranial base, infratemporal fossa, and masticator space developed necrotizing fasciitis and flap failure after initial resection. The resulting skull base defect involved the middle cranial fossa, orbit, and maxilla, with communication into the nasopharynx. Conventional staged reconstructions or local flaps were not feasible because of limited tissue diversity and recipient vessels. A “trimeric” ALT free flap was therefore designed, incorporating 3 tissue components: vastus lateralis muscle, tensor fascia lata, and rectus femoris muscle. Each of these was supplied by perforators from the descending branch of the lateral circumflex femoral artery. This configuration enabled reconstruction of the middle cranial fossa floor, vascularized dural coverage, and restoration of temporalis contour in a single operation. CONCLUSION: This first reported trimeric ALT flap achieved comprehensive restoration of complex cranio-orbital and skull base defects, providing a durable, vascularized, and anatomically adaptable solution for single-stage reconstruction.
- Open Access
- 5 July 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (7) , e0301739
Evaluating soluble Axl as a biomarker for glioblastoma: A pilot study
With current imaging, discriminating tumor progression from treatment effect following immunotherapy or oncolytic virotherapy of glioblastoma (GBM) is challenging. A blood based diagnostic biomarker would therefore be helpful. Axl is a receptor tyrosine kinase that is highly expressed by many cancers including GBM. Axl expression is regulated through enzymatic cleavage of its extracellular domain. The resulting fragment can be detected in serum as soluble Axl (sAxl). sAxl levels can distinguish patients with melanoma, hepatocellular carcinoma, and pancreatic ductal adenocarcinoma from healthy controls. This is a pilot study to determine if sAxl is a candidate biomarker for GBM. The sAxl levels in the serum of 40 healthy volunteers and 20 GBM patients were determined using an enzyme-linked immunosorbent assay (ELISA). Pre- and post- operative sAxl levels were obtained. Volumetric MRI evaluation provided GBM tumor volume metrics. There was no significant difference in the sAxl levels of the volunteers (30.16±1.88 ng/ml) and GBM patients (30.74±1.96 ng/ml) p = 0.27. The postoperative sAxl levels were significantly higher than preoperative levels (32.32±2.26 ng/ml vs 30.74±1.96 ng/ml, p = 0.03). We found no correlation between tumor volume and sAxl levels. Axl expression was low or absent in 6 of 11 (55%) patient derived GBM cell lines. Given the wide range of Axl expression by GBM tumors, sAxl may not be a reliable indicator of GBM. However, given the small sample size in this study, a larger study may be considered.
- 5 July 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (7) , e0301739
Open AccessEvaluating soluble Axl as a biomarker for glioblastoma: A pilot study
With current imaging, discriminating tumor progression from treatment effect following immunotherapy or oncolytic virotherapy of glioblastoma (GBM) is challenging. A blood based diagnostic biomarker would therefore be helpful. Axl is a receptor tyrosine kinase that is highly expressed by many cancers including GBM. Axl expression is regulated through enzymatic cleavage of its extracellular domain. The resulting fragment can be detected in serum as soluble Axl (sAxl). sAxl levels can distinguish patients with melanoma, hepatocellular carcinoma, and pancreatic ductal adenocarcinoma from healthy controls. This is a pilot study to determine if sAxl is a candidate biomarker for GBM. The sAxl levels in the serum of 40 healthy volunteers and 20 GBM patients were determined using an enzyme-linked immunosorbent assay (ELISA). Pre- and post- operative sAxl levels were obtained. Volumetric MRI evaluation provided GBM tumor volume metrics. There was no significant difference in the sAxl levels of the volunteers (30.16±1.88 ng/ml) and GBM patients (30.74±1.96 ng/ml) p = 0.27. The postoperative sAxl levels were significantly higher than preoperative levels (32.32±2.26 ng/ml vs 30.74±1.96 ng/ml, p = 0.03). We found no correlation between tumor volume and sAxl levels. Axl expression was low or absent in 6 of 11 (55%) patient derived GBM cell lines. Given the wide range of Axl expression by GBM tumors, sAxl may not be a reliable indicator of GBM. However, given the small sample size in this study, a larger study may be considered.
- Open Access
Evaluating soluble Axl as a biomarker for glioblastoma: a pilot study
With current imaging, discriminating tumor progression from treatment effect following immunotherapy or oncolytic virotherapy of glioblastoma (GBM) is challenging. A blood based diagnostic biomarker would therefore be helpful. Axl is a receptor tyrosine kinase that is highly expressed by many cancers including GBM. Axl expression is regulated through enzymatic cleavage of its extracellular domain. The resulting fragment can be detected in serum as soluble Axl (sAxl). sAxl levels can distinguish patients with melanoma, hepatocellular carcinoma, and pancreatic ductal adenocarcinoma from healthy controls. This is a pilot study to determine if sAxl is a candidate biomarker for GBM. The sAxl levels in the serum of 40 healthy volunteers and 20 GBM patients were determined using an enzyme-linked immunosorbent assay (ELISA). Pre- and post-operative sAxl levels were obtained. Volumetric MRI evaluation provided GBM tumor volume metrics. There was no significant difference in the sAxl levels of the volunteers (30.16±1.88 ng/ml) and GBM patients (30.74±1.96 ng/ml) p=0.27. The postoperative sAxl levels were significantly higher than preoperative levels (32.32±2.26 ng/ml vs 30.74±1.96 ng/ml, p=0.03). We found no correlation between tumor volume and sAxl levels. Axl expression was low or absent in 6 of 11 (55%) patient derived GBM cell lines. Given the wide range of Axl expression by GBM tumors, sAxl may not be a reliable indicator of GBM. However, given the small sample size in this study, a larger study may be considered.
Open AccessEvaluating soluble Axl as a biomarker for glioblastoma: a pilot study
With current imaging, discriminating tumor progression from treatment effect following immunotherapy or oncolytic virotherapy of glioblastoma (GBM) is challenging. A blood based diagnostic biomarker would therefore be helpful. Axl is a receptor tyrosine kinase that is highly expressed by many cancers including GBM. Axl expression is regulated through enzymatic cleavage of its extracellular domain. The resulting fragment can be detected in serum as soluble Axl (sAxl). sAxl levels can distinguish patients with melanoma, hepatocellular carcinoma, and pancreatic ductal adenocarcinoma from healthy controls. This is a pilot study to determine if sAxl is a candidate biomarker for GBM. The sAxl levels in the serum of 40 healthy volunteers and 20 GBM patients were determined using an enzyme-linked immunosorbent assay (ELISA). Pre- and post-operative sAxl levels were obtained. Volumetric MRI evaluation provided GBM tumor volume metrics. There was no significant difference in the sAxl levels of the volunteers (30.16±1.88 ng/ml) and GBM patients (30.74±1.96 ng/ml) p=0.27. The postoperative sAxl levels were significantly higher than preoperative levels (32.32±2.26 ng/ml vs 30.74±1.96 ng/ml, p=0.03). We found no correlation between tumor volume and sAxl levels. Axl expression was low or absent in 6 of 11 (55%) patient derived GBM cell lines. Given the wide range of Axl expression by GBM tumors, sAxl may not be a reliable indicator of GBM. However, given the small sample size in this study, a larger study may be considered.
- Open Access
- 1 December 2016
- Published by Elsevier in Interdisciplinary Neurosurgery
- Vol. 6, 55-61
White matter tract recovery following medial temporal lobectomy and selective amygdalohippocampectomy for tumor resection via a ROVOT-m port-guided technique: A case report and review of literature
- 1 December 2016
- Published by Elsevier in Interdisciplinary Neurosurgery
- Vol. 6, 55-61
Open AccessWhite matter tract recovery following medial temporal lobectomy and selective amygdalohippocampectomy for tumor resection via a ROVOT-m port-guided technique: A case report and review of literature
- 1 February 2016
- Published by Georg Thieme Verlag KG in Journal of Neurological Surgery Part B: Skull Base
- Vol. 77 (S 01) , A131
First in Human Application of a Novel Integrated Image Guided Robotic Optical Telescopic Microscopy Positioning System: Cerebrovascular Surgical Applications
Introduction: Since its introduction in Neurosurgery 50 years ago, the operating microscope has proved indispensable. Over the last several years there has been a significant evolution in optical imaging, robotics and image guidance; recently, an FDA listed robotic optics positioning system has been released for clinical use. At high optical zoom (2X) and a 25 cm working distance, the image guided robotics platform can achieve a field of view of 2.5 cm, similar to the state of the art operating microscope; however, its depth of field is 14 mm, 3X that of the operating microscope thus creating a significantly larger immersive surgical environment. This suggests that the robotic optical platform may have an application in cerebrovascular surgery. To understand the feasibility of introducing this platform to vascular Neurosurgery, this correlative cadaveric and clinical study was undertaken. Methods: To demonstrate the effective volume of view (VoV) with the operating microscope and the robotic optical platform, a cadaveric dissection simulating craniotomy for anterior circulation aneurysm was performed. Clinical feasibility of the use of the robotic optical platform was demonstrated during aneurysm surgery. Results: Videos of the relevant cadaveric anatomy will be presented, defining the anatomic boundaries of the VoV seen with each modality. Operative videos that demonstrate the clinical value of the increased immersive surgical environment afforded by the robotic optical system will also be presented. Between April and July of 2015, four patients with anterior circulation aneurysms were operated on using the image guided robotics platform. There were 3 MCA aneurysms (one acutely ruptured MCA aneurysm, one ruptured and partially coiled and one unruptured), and an unruptured paraophthalmic/carotid cave aneurysm. All surgeries were completed using the robotic optics platform without the need to revert to the conventional microscope. Conclusions: With this first clinical use of the image guided robotic optics platform, the following advantages were noted: • the larger immersive volume of surgical anatomy in focus mitigated the absence of stereoscopic vision and any theoretical loss of 3D. • the larger volume of view permitted more of the osseous framework and neurovascular structures to be seen simultaneously, obviating the need for frequent refocusing. This was especially valuable when temporary clipping in the cases of MCA aneurysm as the VoV extended from proximal ICA to distal M2 branches. • two surgeons using four hands can operate comfortably. • the use of preset positions permits multiple relevant optical trajectories to be viewed rapidly and in sequence which is particularly beneficial for temporary clip placement and assessing multiple angles for clip and blade placement. • hands free positioning allows for uninterrupted work flow. • the robotic optics platform has a smaller footprint in the operating room. • there is a significant ergonomic benefit for the surgeon and learners as all have the same high definition view.
- 1 February 2016
- Published by Georg Thieme Verlag KG in Journal of Neurological Surgery Part B: Skull Base
- Vol. 77 (S 01) , A131
First in Human Application of a Novel Integrated Image Guided Robotic Optical Telescopic Microscopy Positioning System: Cerebrovascular Surgical Applications
Introduction: Since its introduction in Neurosurgery 50 years ago, the operating microscope has proved indispensable. Over the last several years there has been a significant evolution in optical imaging, robotics and image guidance; recently, an FDA listed robotic optics positioning system has been released for clinical use. At high optical zoom (2X) and a 25 cm working distance, the image guided robotics platform can achieve a field of view of 2.5 cm, similar to the state of the art operating microscope; however, its depth of field is 14 mm, 3X that of the operating microscope thus creating a significantly larger immersive surgical environment. This suggests that the robotic optical platform may have an application in cerebrovascular surgery. To understand the feasibility of introducing this platform to vascular Neurosurgery, this correlative cadaveric and clinical study was undertaken. Methods: To demonstrate the effective volume of view (VoV) with the operating microscope and the robotic optical platform, a cadaveric dissection simulating craniotomy for anterior circulation aneurysm was performed. Clinical feasibility of the use of the robotic optical platform was demonstrated during aneurysm surgery. Results: Videos of the relevant cadaveric anatomy will be presented, defining the anatomic boundaries of the VoV seen with each modality. Operative videos that demonstrate the clinical value of the increased immersive surgical environment afforded by the robotic optical system will also be presented. Between April and July of 2015, four patients with anterior circulation aneurysms were operated on using the image guided robotics platform. There were 3 MCA aneurysms (one acutely ruptured MCA aneurysm, one ruptured and partially coiled and one unruptured), and an unruptured paraophthalmic/carotid cave aneurysm. All surgeries were completed using the robotic optics platform without the need to revert to the conventional microscope. Conclusions: With this first clinical use of the image guided robotic optics platform, the following advantages were noted: • the larger immersive volume of surgical anatomy in focus mitigated the absence of stereoscopic vision and any theoretical loss of 3D. • the larger volume of view permitted more of the osseous framework and neurovascular structures to be seen simultaneously, obviating the need for frequent refocusing. This was especially valuable when temporary clipping in the cases of MCA aneurysm as the VoV extended from proximal ICA to distal M2 branches. • two surgeons using four hands can operate comfortably. • the use of preset positions permits multiple relevant optical trajectories to be viewed rapidly and in sequence which is particularly beneficial for temporary clip placement and assessing multiple angles for clip and blade placement. • hands free positioning allows for uninterrupted work flow. • the robotic optics platform has a smaller footprint in the operating room. • there is a significant ergonomic benefit for the surgeon and learners as all have the same high definition view.
- 1 February 2016
- Published by Georg Thieme Verlag KG in Journal of Neurological Surgery Part B: Skull Base
- Vol. 77 (S 01) , A128
The Role of Diffusion Tensor Imaging in Skull Base Surgery
Introduction: There has been increasing interest in and clinical utilization of diffusion tensor imaging (DTI) in Neurosurgery to define white matter tracts and cranial nerves to reduce surgical morbidity. Barriers to the use of DTI in skull base surgery include: 1. geometric inaccuracy with “co-registration” of DTI onto anatomic T1 imaging because of errors in warp correction, 2. inability to use multimodality imaging, 3. lack of 3D rendering that can be manipulated in realtime for surgical trajectory planning, and 4. lengthy processing times. Methods: We report our experience with 50 cases of varied skull base procedures with a recently FDA approved 3D DTI planning system Bright Matter Plan (Synaptive Medical, Toronto, Canada). Tractography data are generated by first performing brain extraction (via template initialization and level set evolution) and skin surface detection (via image statistics). Next the raw diffusion dataset is then corrected for motion and eddy current artifacts. Then this diffusion data are co-registered to an anatomical target (e.g., T1 or T2 contrast volume) using a mutual information metric to find a rigid co-registration matrix. Now the raw diffusion data are used to estimate diffusion tensors (via a dual basis solver) in the anatomical space. Noise in the tensor estimate outside the cranium is attenuated using the surface mask, while the brain mask is used to define a tractography region. Whole brain seeding is then used to generate tracts using a deterministic 4th order Runge-Kutta interpolator. Finally, a cleanup pass is performed to remove noise in the tract data as well as perform geometric simplification of the tract objects. Results: In all cases we were able to obtain accurate 3D geometric fits with multimodality rendering. Processing times of 15min from image acquisition in a automated process improved the ergonomics and minimized the resources needed for processing. The rendering platform accurately merged multiple imaging modalities simultaneously and was transferred to the navigation and robotic optical positioning systems. As a representative example the case of a large olfactory groove meningioma is shown. The perimeter location of the bilateral inferior frontal occipital fibers and the superior longitudinal fasciculus was helpful in selecting an endonasal corridor for this lesion as opposed to a transcranial route. Conclusions: As skull base surgery evolves and recognizes neurocognitive morbidity, the identification of critical fibers that subserve these eloquent processes need to be considered during preoperative planning. BrightMatter Plan addresses the aforementioned barriers: • The ability to plan in multiple orthogonal axes simultaneously and simulate the procedure taking into account the critical position of cranial nerves and fiber tracts was found most useful in large anterior and posterolateral skull base pathologies. • The emergence of an integrated DTI planning system that is quick (15 minute processing time), geometrically accurate, and includes real time 3D rendering that can be fused with multiple imaging modalities represents a valuable surgical tool. • Increasing experience will be needed to correlate postoperative tract preservation with outcome to understand the optimal corridors for skull base surgery based on previously “invisible” anatomy.
- 1 February 2016
- Published by Georg Thieme Verlag KG in Journal of Neurological Surgery Part B: Skull Base
- Vol. 77 (S 01) , A128
The Role of Diffusion Tensor Imaging in Skull Base Surgery
Introduction: There has been increasing interest in and clinical utilization of diffusion tensor imaging (DTI) in Neurosurgery to define white matter tracts and cranial nerves to reduce surgical morbidity. Barriers to the use of DTI in skull base surgery include: 1. geometric inaccuracy with “co-registration” of DTI onto anatomic T1 imaging because of errors in warp correction, 2. inability to use multimodality imaging, 3. lack of 3D rendering that can be manipulated in realtime for surgical trajectory planning, and 4. lengthy processing times. Methods: We report our experience with 50 cases of varied skull base procedures with a recently FDA approved 3D DTI planning system Bright Matter Plan (Synaptive Medical, Toronto, Canada). Tractography data are generated by first performing brain extraction (via template initialization and level set evolution) and skin surface detection (via image statistics). Next the raw diffusion dataset is then corrected for motion and eddy current artifacts. Then this diffusion data are co-registered to an anatomical target (e.g., T1 or T2 contrast volume) using a mutual information metric to find a rigid co-registration matrix. Now the raw diffusion data are used to estimate diffusion tensors (via a dual basis solver) in the anatomical space. Noise in the tensor estimate outside the cranium is attenuated using the surface mask, while the brain mask is used to define a tractography region. Whole brain seeding is then used to generate tracts using a deterministic 4th order Runge-Kutta interpolator. Finally, a cleanup pass is performed to remove noise in the tract data as well as perform geometric simplification of the tract objects. Results: In all cases we were able to obtain accurate 3D geometric fits with multimodality rendering. Processing times of 15min from image acquisition in a automated process improved the ergonomics and minimized the resources needed for processing. The rendering platform accurately merged multiple imaging modalities simultaneously and was transferred to the navigation and robotic optical positioning systems. As a representative example the case of a large olfactory groove meningioma is shown. The perimeter location of the bilateral inferior frontal occipital fibers and the superior longitudinal fasciculus was helpful in selecting an endonasal corridor for this lesion as opposed to a transcranial route. Conclusions: As skull base surgery evolves and recognizes neurocognitive morbidity, the identification of critical fibers that subserve these eloquent processes need to be considered during preoperative planning. BrightMatter Plan addresses the aforementioned barriers: • The ability to plan in multiple orthogonal axes simultaneously and simulate the procedure taking into account the critical position of cranial nerves and fiber tracts was found most useful in large anterior and posterolateral skull base pathologies. • The emergence of an integrated DTI planning system that is quick (15 minute processing time), geometrically accurate, and includes real time 3D rendering that can be fused with multiple imaging modalities represents a valuable surgical tool. • Increasing experience will be needed to correlate postoperative tract preservation with outcome to understand the optimal corridors for skull base surgery based on previously “invisible” anatomy.
- 15 November 2003
- Published by Springer Nature
- p. 273-292
Imaging Neurologic Manifestations of Oncologic Disease
- 15 November 2003
- Published by Springer Nature
- p. 273-292
Imaging Neurologic Manifestations of Oncologic Disease
- 1 April 2002
- Published by Springer Nature in Neuroradiology
- Vol. 44 (4) , 342-346
Venous angioma adjacent to the root entry zone of the trigeminal nerve: implications for management of trigeminal neuralgia
Detection of a venous angioma at the root entry zone is important for surgical planning, so that the neurosurgeon will be aware that both veins and arteries may require microvascular decompression. In selected cases, alternative treatment may be indicated to avoid the potential surgical complication of a venous infarct. Trigeminal neuralgia typically occurs in the middle-aged to elderly population, usually the result of compression of the trigeminal nerve at its root entry zone by an ectatic, aging artery or, less commonly, a regional vein [1, 2, 3]. When associated with a venous angioma at the root entry zone, trigeminal neuralgia usually presents at a younger age [4, 5, 6]. We review the imaging examinations and clinical data of five patients with trigeminal neuralgia who had a venous angioma adjacent to the root entry zone of the trigeminal nerve, and discuss how the imaging findings affected their management.
- 1 April 2002
- Published by Springer Nature in Neuroradiology
- Vol. 44 (4) , 342-346
Venous angioma adjacent to the root entry zone of the trigeminal nerve: implications for management of trigeminal neuralgia
Detection of a venous angioma at the root entry zone is important for surgical planning, so that the neurosurgeon will be aware that both veins and arteries may require microvascular decompression. In selected cases, alternative treatment may be indicated to avoid the potential surgical complication of a venous infarct. Trigeminal neuralgia typically occurs in the middle-aged to elderly population, usually the result of compression of the trigeminal nerve at its root entry zone by an ectatic, aging artery or, less commonly, a regional vein [1, 2, 3]. When associated with a venous angioma at the root entry zone, trigeminal neuralgia usually presents at a younger age [4, 5, 6]. We review the imaging examinations and clinical data of five patients with trigeminal neuralgia who had a venous angioma adjacent to the root entry zone of the trigeminal nerve, and discuss how the imaging findings affected their management.